BioWorld

Feb. 2, 1996

View Archived Issues

SENATE FDA REFORM HEARINGS SET; COMPROMISE REMAINS ELUSIVE

Read More

CONNECTIVE TO FUND NUMBER OF STUDIES WITH IPO PROCEEDS

Read More

AMGEN'S `95 EARNINGS UP 23 PERCENT STUDY RAISES QUESTIONS ABOUT VALUE

Read More

ABBOTT WOWS RETROVIRUS CONFERENCE WITH MORTALITY DATA

Read More

PCR-BASED BLADDER CANCER TEST SCORES 95% VS. 50% FOR CONVENTIONAL

Read More

BRITISH BIOTECH RAISES $70M, BOOSTING 1994 RIGHTS OFFERING TOTAL TO

Read More